Clinical questions. Practical possibilities.

Research & AI

Dr Ghaffari’s work in clinical genetics, genomic diagnostics and the application of AI and digital tools.

Research

Research & clinical interests

Clinical genetics
Evaluation of inherited disorders across prenatal, pediatric and adult care.
Genomic diagnostics
Application and interpretation of sequencing, copy-number and cytogenetic methods.
Reproductive genetics & preimplantation testing
PGT-A, PGT-SR and PGT-M; prenatal screening and diagnosis; infertility and recurrent pregnancy loss.
Precision medicine
Connecting molecular findings with clinically meaningful decisions and follow-up.
AI experience in clinical applications
Responsible use of artificial intelligence to support clinical workflows, interpretation and medical communication.
Research & education
Collaborative studies, laboratory development and communication of genetic knowledge.
Application development capabilities
Clinical requirements, workflow design, AI-assisted implementation and acceptance testing for research, education and laboratory applications.

Selected research and screening programs

Mucopolysaccharidosis (MPS)
Molecular characterization and diagnostic reassessment, including the IMPRESsion study of 302 patients from 289 families.
Inherited retinal disease & retinitis pigmentosa (RP)
Targeted and exome sequencing, molecular diagnosis and genotype–phenotype studies in inherited retinal disorders.
Newborn screening (NBS)
Research and implementation experience in screening for inherited metabolic disorders using tandem mass spectrometry (MS/MS).
Down syndrome & prenatal screening
Evaluation of prenatal-screening risk software, analysis of screening data and a national program evaluating 500 screening laboratories.
AI-assisted application development & clinical informatics

Clinical requirements, workflow design, AI-assisted implementation and acceptance testing for laboratory and counseling applications.

Clinical workflow applications
Configurable workflows, role-based access, structured evidence and controlled reporting.
Bilingual clinical portals
Patient intake, document handling, counselor work queues and follow-up workflows.
Laboratory information systems
Test catalogs, specimen workflows, quality documentation and reporting; laboratory information systems remain development projects.

National research

Population-based studies in Iran

Dr Ghaffari designed national, population-based studies addressing inherited disorders and screening in the Iranian population.

Mucopolysaccharidosis (MPS) · 2018
Study design for molecular characterization and diagnostic reassessment, beginning in 2018.
Retinitis pigmentosa (RP) · 2009
Study beginning in 2009, encompassing 3,950 Iranian families.
Newborn screening (NBS) · 2008
Project beginning in 2008: expanded newborn screening for inherited metabolic disorders using tandem mass spectrometry.
Down syndrome screening · 2005
Screening-data program beginning in 2005, with 101,000 pregnancy records.

Reproductive genetics

Clinical PGT experience

His PGT-A and PGT-SR clinical work encompasses approximately 200 families and more than 1,000 embryos, including NGS-based embryo analysis, copy-number interpretation and genetic counseling.

Diagnostic development

First introductions in Iran

Dr Ghaffari’s work includes introducing the following techniques for the first time in Iran:

Genomic and molecular diagnostics
Clinical next-generation sequencing (NGS), multiplex ligation-dependent probe amplification (MLPA), quantitative fluorescent PCR (QF-PCR) and HPV genotyping.
Prenatal and newborn screening
First-trimester screening and expanded newborn screening for inherited metabolic disorders using tandem mass spectrometry.
Fluorescence in situ hybridization (FISH)
HER2 amplification testing, and FISH-based preimplantation and prenatal diagnosis.

Recent work · 2026

Clinical direction of software development

Clinical direction of AI-assisted development of laboratory information systems and genetic counseling software (2026), intended for CAP-accredited, CLIA-certified laboratories and designed to support HIPAA compliance; workflow design, structured reporting, quality assurance, genomic-analysis automation and medical-content review.